✦ LIBER ✦

S.08.04 Dopamine D3 receptors as a target for the treatment of schizophrenia: contrasting actions of antipsychotic agents

✍ Scribed by M. Millan

Book ID: 118592477
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 58 KB
Volume: 16
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(06)70055-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine D3 receptor as a new pharmacolo

Dopamine D3 receptor as a new pharmacological target for the treatment of depression

✍ Leggio, Gian Marco; Salomone, Salvatore; Bucolo, Claudio; Platania, Chiara; Mica 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Ave5997, a dopamine D3 antagonist for th

Ave5997, a dopamine D3 antagonist for the treatment of schizophrenia

✍ S. Kongsamut; J. Hendrix; K. Bordeau; J. Strupczewski; B. Harris; M. Kenney; S. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Dopamine-cell depolarization block as a

Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs

✍ Anthony A. Grace; Benjamin S. Bunney; Holly Moore; Christopher L. Todd 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Intrinsic Efficacy of Antipsychotics at

Intrinsic Efficacy of Antipsychotics at Human D2, D3, and D4 Dopamine Receptors: Identification of the Clozapine Metabolite N-Desmethylclozapine as a D2/D3 Partial Agonist

✍ Burstein, E. S. 📂 Article 📅 2005 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 576 KB

Cortical dopamine D2/D3 receptors are a

Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs — An original patient data meta-analysis of the SPET and PET in vivo receptor imaging literature

✍ J.M. Stone; J.M. Davis; S. Leucht; L.S. Pilowsky 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Agonist and antagonist actions of yohimb

Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

✍ Mark J. Millan; Adrian Newman-Tancredi; Valérie Audinot; Didier Cussac; François 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 1 views

Herein, we evaluate the interaction of the ␣ 2 -AR antagonist, yohimbine, as compared to fluparoxan, at multiple monoaminergic receptors and examine their roles in the modulation of adrenergic, dopaminergic and serotonergic transmission in freelymoving rats. Yohimbine displays marked affinity at hum